Summary

Psoriasis is a chronic inflammatory disease, with a strongly expressed immunological component and a wide range of associated comorbidities. The involvement of inflammatory markers in the pathogenesis of the disease has led to increased interest in identifying serum biomarkers that reflect clinical severity and systemic risk.
The present study aims to highlight the correlation between the PASI score and a series of inflammatory markers (ESR, NLR, leukocytes, platelets, eosinophils, basophils) in a group of 55 patients diagnosed with psoriasis vulgaris.
The results of the research indicate a significant association between increased levels of ESR and NLR and moderate/severe forms of the disease. Thus, serum markers of inflammation may represent useful tools in the objective assessment of psoriasis activity and in adjusting therapeutic strategies.